Abstract:The development of bone-like tissues in vitro that exhibit key features similar to those in vivo is needed to produce tissue models for drug screening and the study of bone physiology and disease pathogenesis. Extracellular matrix (ECM) is a predominant component of bone in vivo; however, as ECM assembly is sub-optimal in vitro, current bone tissue engineering approaches are limited by an imbalance in ECM-to-cell ratio. We amplified the deposition of osteoblastic ECM by supplementing dextran sulfate (DxS) into osteogenically induced cultures of human mesenchymal stem cells (MSCs). DxS, previously implicated to act as a macromolecular crowder, was recently demonstrated to aggregate and co-precipitate major ECM components, including collagen type I, thereby amplifying its deposition. This effect was re-confirmed for MSC cultures undergoing osteogenic induction, where DxS supplementation augmented collagen type I deposition, accompanied by extracellular osteocalcin accumulation. The resulting differentiated osteoblasts exhibited a more mature osteogenic gene expression profile, indicated by a strong upregulation of the intermediate and late osteogenic markers ALP and OCN, respectively. The associated cellular microenvironment was also enriched in bone morphogenetic protein 2 (BMP-2). Interestingly, the resulting decellularized matrices exhibited the strongest osteo-inductive effects on re-seeded MSCs, promoted cell proliferation, osteogenic marker expression and ECM calcification. Taken together, these findings suggest that DxS-mediated enhancement of osteogenic differentiation by MSCs is mediated by the amplified ECM, which is enriched in osteo-inductive factors. We have thus established a simple and reproducible approach to generate ECM-rich bone-like tissue in vitro with sequestration of osteo-inductive factors. STATEMENT OF SIGNIFICANCE: As extracellular matrix (ECM) assembly is significantly retarded in vitro, the imbalance in ECM-to-cell ratio hampers current in vitro bone tissue engineering approaches in their ability to faithfully resemble their in vivo counterpart. We addressed this limitation by leveraging a poly-electrolyte mediated co-assembly and amplified deposition of ECM during osteogenic differentiation of human mesenchymal stem cells (MSCs). The resulting pericelluar space in culture was enriched in organic and inorganic bone ECM components, as well as osteo-inductive factors, which promoted the differentiation of MSCs towards a more mature osteoblastic phenotype. These findings thus demonstrated a simple and reproducible approach to generate ECM-rich bone-like tissue in vitro with a closer recapitulation of the in vivo tissue niche.

Response of Human Embryonic Stem Cell-Derived Mesenchymal Stem Cells to Osteogenic Factors and Architectures of Materials During in Vitro Osteogenesis.

Human Embryonic Stem Cell Differentiation into Odontoblastic Lineage: an in Vitro Study.

Short Periods of Cyclic Mechanical Strain Enhance Triple-Supplement Directed Osteogenesis and Bone Nodule Formation by Human Embryonic Stem Cells in Vitro

Human Mesenchymal Stem Cell Derived Exosomes Enhance Cell‐Free Bone Regeneration by Altering Their Mirnas Profiles

A Cancellous Bone Matrix System with Specific Mineralisation Degrees for Mesenchymal Stem Cell Differentiation and Bone Regeneration

In vivo bone formation by progeny of human embryonic stem cells

Dextran sulfate-amplified extracellular matrix deposition promotes osteogenic differentiation of mesenchymal stem cells

The Enhancement of human embryonic stem cell osteogenic differentiation with nano-fibrous scaffolding

In Vitro Osteogenic Induction of Bone Marrow Mesenchymal Stem Cells with A Decellularized Matrix Derived from Human Adipose Stem Cells and in Vivo Implantation for Bone Regeneration

Evaluation of human mesenchymal stem cells response to biomimetic bioglass-collagen-hyaluronic acid-phosphatidylserine composite scaffolds for bone tissue engineering.

BMP-2 Enhances Osteogenic Differentiation of Human Adipose-Derived and Dental Pulp Stem Cells in 2D and 3D In Vitro Models

ECTOPIC OSTEOGENESIS OF IMMORTALIZED HUMAN BONE MARROW MESENCHYMAL STEM CELLS AND HETEROGENEOUS BONE

Comparison of osteogenesis of human embryonic stem cells within 2D and 3D culture systems

Osteogenic differentiation of human amniotic fluid-derived stem cells induced by bone morphogenetic protein-7 and enhanced by nanofibrous scaffolds.

[Bone Formation in Vitro and in Vivo by Human Bone Marrow-Derived Mesenchymal Stem Cells].

Microsphere-based drug releasing scaffolds for inducing osteogenesis of human mesenchymal stem cells in vitro.

Human Amniotic Mesenchymal Stromal Cells Promote Bone Regeneration Via Activating Endogenous Regeneration

Enhanced Bone Tissue Regeneration of a Biomimetic Cellular Scaffold with Co-Cultured MSCs-derived Osteogenic and Angiogenic Cells

Superior Mineralization and Neovascularization Capacity of Adult Human Metaphyseal Periosteum-Derived Cells for Skeletal Tissue Engineering Applications.

Pretreating mesenchymal stem cells with electrical stimulation causes sustained long-lasting pro-osteogenic effects

Characterization of Human Ethmoid Sinus Mucosa Derived Mesenchymal Stem Cells (hesmscs) and the Application of Hesmscs Cell Sheets in Bone Regeneration.